PerkinElmer Inc (PKI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH1708D
- Pages: 59
- October 2018
- Total Views:1150
- Region : North America
- GlobalData
- Equity Research Report
Details
Summary
PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services to diagnostics, research, food, laboratory services, environmental, and industrial markets. The company's major products include cytogenetics reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography instruments, molecular spectroscopy, newborn screening instruments and thermal analysis instruments, among others. It offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. PerkinElmer also offers cord blood and tissue banking, laboratory and research services, among others. Its products are used in various applications, including atomic spectroscopy, cell imaging and analysis, chromatography, DNA/RNA isolation, analysis and detection, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others. The company operates in Asia-Pacific, Europe and North America, among others. PerkinElmer is headquartered in Waltham, Massachusetts, US.
PerkinElmer Inc (PKI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PerkinElmer Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
PerkinElmer Inc, Medical Devices Deals, 2012 to YTD 2018 10
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Enzyvant Enters into Collaboration Agreement PerkinElmer 13
Nightingale Health Enters into Agreement with PerkinElmer 14
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 15
Albany Molecular Research Enters into Agreement with PerkinElmer 16
Reproductive Health Science Enters into Distribution Agreement with Delfran Pharma 17
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 18
ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 19
PerkinElmer Enters Into Agreement With National Center for Drug Screening 20
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 21
Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 22
Licensing Agreements 23
Bioo Scientific Enters into Licensing Agreement with Icahn School of Medicine 23
Trinean Enters Into Licensing Agreement With Perkinelmer For Microfluidics Technology 24
Debt Offering 25
PerkinElmer Raises USD370.1 Million in Public Offering of 0.6% Notes Due 2021 25
PerkinElmer Raises EUR553 Million in Public Offering of 1.875% Notes Due 2026 26
Acquisition 27
PerkinElmer to Acquire RHS for up to USD19.7 Million 27
PerkinElmer Acquires Bioo Scientific for USD63.5 Million 28
PerkinElmer Acquires Ceiba Solutions 29
AO Energy Completes Acquisition of Reproductive Health Science 30
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech 31
PerkinElmer Inc-Key Competitors 32
PerkinElmer Inc-Key Employees 33
PerkinElmer Inc-Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Joint Venture 39
Recent Developments 40
Strategy And Business Planning 40
Sep 21, 2017: State Key Laboratory of Biochemical Engineering and PerkinElmer Open Joint Translational Medical Engineering Demonstration Laboratory in Beijing 40
Financial Announcements 41
Aug 01, 2018: PerkinElmer Announces Financial Results for the Second Quarter of 2018 41
Apr 30, 2018: PerkinElmer Reports Financial Results for the First Quarter of 2018 42
Jan 25, 2018: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017 43
Nov 02, 2017: PerkinElmer Announces Financial Results for the Third Quarter of 2017 45
Aug 03, 2017: PerkinElmer Announces Financial Results for the Second Quarter of 2017 46
May 04, 2017: PerkinElmer Announces Financial Results for the First Quarter of 2017 47
Feb 02, 2017: PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2016 48
Corporate Communications 50
Apr 10, 2018: PerkinElmer Names James Mock as Chief Financial Officer 50
Oct 30, 2017: PerkinElmer Elects Pascale Witz to its Board of Directors 51
Sep 15, 2017: PerkinElmer Announces Future Retirement of Andy Wilson, Chief Financial Officer 52
Product News 53
Oct 31, 2017: Phase II Clinical Trial Data Establishes Effectiveness of using a Child's Own Cord Blood to Treat Cerebral Palsy 53
Mar 23, 2017: PerkinElmer to Display Portfolio of Cancer Research Technologies and Workflow Solutions at 2017 AACR Annual Meeting 54
Jan 23, 2017: PerkinElmer's NexION 2000 ICP-MS Provides Industry-Leading Versatility for Trace Elemental Analyses 56
Other Significant Developments 57
Apr 05, 2018: Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program 57
Sep 07, 2017: PerkinElmer Extends Clinical Whole Genome Sequencing Services 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
List Of Figure
List of Figures
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
PerkinElmer Inc, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
PerkinElmer Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PerkinElmer Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PerkinElmer Inc, Deals By Therapy Area, 2012 to YTD 2018 9
PerkinElmer Inc, Medical Devices Deals, 2012 to YTD 2018 10
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Enzyvant Enters into Collaboration Agreement PerkinElmer 13
Nightingale Health Enters into Agreement with PerkinElmer 14
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 15
Albany Molecular Research Enters into Agreement with PerkinElmer 16
Reproductive Health Science Enters into Distribution Agreement with Delfran Pharma 17
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 18
ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 19
PerkinElmer Enters Into Agreement With National Center for Drug Screening 20
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 21
Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 22
Bioo Scientific Enters into Licensing Agreement with Icahn School of Medicine 23
Trinean Enters Into Licensing Agreement With Perkinelmer For Microfluidics Technology 24
PerkinElmer Raises USD370.1 Million in Public Offering of 0.6% Notes Due 2021 25
PerkinElmer Raises EUR553 Million in Public Offering of 1.875% Notes Due 2026 26
PerkinElmer to Acquire RHS for up to USD19.7 Million 27
PerkinElmer Acquires Bioo Scientific for USD63.5 Million 28
PerkinElmer Acquires Ceiba Solutions 29
AO Energy Completes Acquisition of Reproductive Health Science 30
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech 31
PerkinElmer Inc, Key Competitors 32
PerkinElmer Inc, Key Employees 33
PerkinElmer Inc, Other Locations 34
PerkinElmer Inc, Subsidiaries 35
PerkinElmer Inc, Joint Venture 39
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
PerkinElmer Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services to diagnostics, research, food, laboratory services, environmental, and industrial markets. The company's major products include cytogenetics reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography instruments, molecular spectroscopy, newborn screening instruments and thermal analysis instruments, among others. It offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. PerkinElmer also offers cord blood and tissue banking, laboratory and research services, among others. Its products are used in various applications, including atomic spectroscopy, cell imaging and analysis, chromatography, DNA/RNA isolation, analysis and detection, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others. The company operates in Asia-Pacific, Europe and North America, among others. PerkinElmer is headquartered in Waltham, Massachusetts, US.
PerkinElmer Inc (PKI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PerkinElmer Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
PerkinElmer Inc, Medical Devices Deals, 2012 to YTD 2018 10
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Enzyvant Enters into Collaboration Agreement PerkinElmer 13
Nightingale Health Enters into Agreement with PerkinElmer 14
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 15
Albany Molecular Research Enters into Agreement with PerkinElmer 16
Reproductive Health Science Enters into Distribution Agreement with Delfran Pharma 17
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 18
ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 19
PerkinElmer Enters Into Agreement With National Center for Drug Screening 20
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 21
Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 22
Licensing Agreements 23
Bioo Scientific Enters into Licensing Agreement with Icahn School of Medicine 23
Trinean Enters Into Licensing Agreement With Perkinelmer For Microfluidics Technology 24
Debt Offering 25
PerkinElmer Raises USD370.1 Million in Public Offering of 0.6% Notes Due 2021 25
PerkinElmer Raises EUR553 Million in Public Offering of 1.875% Notes Due 2026 26
Acquisition 27
PerkinElmer to Acquire RHS for up to USD19.7 Million 27
PerkinElmer Acquires Bioo Scientific for USD63.5 Million 28
PerkinElmer Acquires Ceiba Solutions 29
AO Energy Completes Acquisition of Reproductive Health Science 30
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech 31
PerkinElmer Inc-Key Competitors 32
PerkinElmer Inc-Key Employees 33
PerkinElmer Inc-Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Joint Venture 39
Recent Developments 40
Strategy And Business Planning 40
Sep 21, 2017: State Key Laboratory of Biochemical Engineering and PerkinElmer Open Joint Translational Medical Engineering Demonstration Laboratory in Beijing 40
Financial Announcements 41
Aug 01, 2018: PerkinElmer Announces Financial Results for the Second Quarter of 2018 41
Apr 30, 2018: PerkinElmer Reports Financial Results for the First Quarter of 2018 42
Jan 25, 2018: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017 43
Nov 02, 2017: PerkinElmer Announces Financial Results for the Third Quarter of 2017 45
Aug 03, 2017: PerkinElmer Announces Financial Results for the Second Quarter of 2017 46
May 04, 2017: PerkinElmer Announces Financial Results for the First Quarter of 2017 47
Feb 02, 2017: PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2016 48
Corporate Communications 50
Apr 10, 2018: PerkinElmer Names James Mock as Chief Financial Officer 50
Oct 30, 2017: PerkinElmer Elects Pascale Witz to its Board of Directors 51
Sep 15, 2017: PerkinElmer Announces Future Retirement of Andy Wilson, Chief Financial Officer 52
Product News 53
Oct 31, 2017: Phase II Clinical Trial Data Establishes Effectiveness of using a Child's Own Cord Blood to Treat Cerebral Palsy 53
Mar 23, 2017: PerkinElmer to Display Portfolio of Cancer Research Technologies and Workflow Solutions at 2017 AACR Annual Meeting 54
Jan 23, 2017: PerkinElmer's NexION 2000 ICP-MS Provides Industry-Leading Versatility for Trace Elemental Analyses 56
Other Significant Developments 57
Apr 05, 2018: Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program 57
Sep 07, 2017: PerkinElmer Extends Clinical Whole Genome Sequencing Services 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
List Of Figure
List of Figures
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
PerkinElmer Inc, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
PerkinElmer Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PerkinElmer Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PerkinElmer Inc, Deals By Therapy Area, 2012 to YTD 2018 9
PerkinElmer Inc, Medical Devices Deals, 2012 to YTD 2018 10
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Enzyvant Enters into Collaboration Agreement PerkinElmer 13
Nightingale Health Enters into Agreement with PerkinElmer 14
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 15
Albany Molecular Research Enters into Agreement with PerkinElmer 16
Reproductive Health Science Enters into Distribution Agreement with Delfran Pharma 17
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 18
ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 19
PerkinElmer Enters Into Agreement With National Center for Drug Screening 20
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 21
Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 22
Bioo Scientific Enters into Licensing Agreement with Icahn School of Medicine 23
Trinean Enters Into Licensing Agreement With Perkinelmer For Microfluidics Technology 24
PerkinElmer Raises USD370.1 Million in Public Offering of 0.6% Notes Due 2021 25
PerkinElmer Raises EUR553 Million in Public Offering of 1.875% Notes Due 2026 26
PerkinElmer to Acquire RHS for up to USD19.7 Million 27
PerkinElmer Acquires Bioo Scientific for USD63.5 Million 28
PerkinElmer Acquires Ceiba Solutions 29
AO Energy Completes Acquisition of Reproductive Health Science 30
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech 31
PerkinElmer Inc, Key Competitors 32
PerkinElmer Inc, Key Employees 33
PerkinElmer Inc, Other Locations 34
PerkinElmer Inc, Subsidiaries 35
PerkinElmer Inc, Joint Venture 39
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
PerkinElmer Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 179 | 
February 2020
Page 116 | January 2020
Page 235 | January 2020
Page 183 | September 2019
Page 244 | August 2019